The role of radiomics and artificial intelligence in predicting and evaluating the efficacy of neoadjuvant chemoradiotherapy for rectal cancer
10.3760/cma.j.cn113030-20220119-00026
- VernacularTitle:影像组学和人工智能在直肠癌疗效预测和评估中的作用
- Author:
Ganlu OUYANG
1
;
Xin WANG
Author Information
1. 四川大学华西医院肿瘤中心腹部肿瘤科，成都 610041
- Keywords:
Artificial intelligence;
Radiomics;
Rectal neoplasms;
Efficacy prediction;
Neoadjuvant therapy
- From:
Chinese Journal of Radiation Oncology
2023;32(4):360-364
- CountryChina
- Language:Chinese
-
Abstract:
Predicting and evaluating the efficacy of neoadjuvant therapy for rectal cancer are of clinical significance and health economic value. At present, exploring the methods of predicting and evaluating the efficacy of neoadjuvant therapy have become research hotspot, focus and difficulty at home and abroad. Radiomics and artificial intelligence (AI) are two rapidly developing technologies. It is worthy of integrating radiomics with AI to build a model for predicting and evaluating the efficacy of neoadjuvant therapy and support individualized clinical decision-making and treatment options. In this article, literature review related to neoadjuvant chemoradiotherapy for rectal cancer based on radiomics and AI was conducted, aiming to explore the prospect and advantages of radiomics and AI in the prediction and evaluation of neoadjuvant therapy.
